Next Article in Journal
Dating Skin Lesions of Forensic Interest by Immunohistochemistry and Immunofluorescence Techniques: A Scoping Literature Review
Previous Article in Journal
Coexistence of Hashimoto’s Thyroiditis in Differentiated Thyroid Cancer: Post-Operative Monitoring of Anti-Thyroglobulin Antibodies and Assessment of Treatment Response
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Reply

Reply to Fujimoto, T. Comment on “Okaniwa, S. How Can We Manage Gallbladder Lesions by Transabdominal Ultrasound? Diagnostics 2021, 11, 784”

Department of Gastroenterology, Iida Municipal Hospital 1, Iida 395-8502, Nagano, Japan
Diagnostics 2024, 14(2), 167; https://doi.org/10.3390/diagnostics14020167
Submission received: 27 November 2023 / Revised: 18 December 2023 / Accepted: 7 January 2024 / Published: 11 January 2024
(This article belongs to the Section Medical Imaging and Theranostics)
Thank you for your interesting comments.
Since this article has targeted the differential diagnosis of gallbladder lesions and the differential diagnosis of T1 or shallow T2 GBC is still controversial, I only mentioned that sessile GPLs with an intact outer hyperechoic layer include not only non-neoplastic GPLs but also GBCs confined to the mucosa (T1a) or muscularis propria (T1b) or that have invaded the fibrous layer of the subserosa (T2).
I think your hypothesis is interesting. However, the conically thickened outermost hyperechogenic layer and deep hypoechoic areas have been reported in only a few case reports, and the frequency, sensitivity, and specificity in large numbers of cases do not seem to have been established. I think review articles should cite ultrasound findings with well-known frequency, sensitivity, and specificity in each disease, and hopefully these data will be clarified.
In another review that you pointed out [1], I only mentioned that a hypoechoic area within the deeper part of GBC with an intact outer hyperechoic layer may suggest invasion into the shallow fibrous layer of the lower serosa but did not cite it as a definite finding.
Contrast enhanced US (CEUS) has several advantages, including the diagnosis of biliary sludge, improved detection of microcystic structures in protruded lesions, and increased Doppler sensitivity. In addition, this review describes that CEUS is very useful in observing the continuity of the GB wall.
These studies are based on EUS; Hashimoto et al. [2] reported that CE-EUS provides enhanced visualization of the layered structure of the GB wall and could be valuable for predicting the depth of invasion. Imazu et al. [3] reported that CH-EUS could show the depth of invasion of biliary cancer (including GBC) more clearly than conventional EUS.
Therefore, I believe that CEUS could also provide more precise visualization of the layered structure of the GB wall, and CEUS with a high-frequency transducer could be valuable for predicting the depth of invasion.
Dr Fujimoto’s Comment has been revised based on Professor Okaniwa’s Reply [4].

Institutional Review Board Statement

All procedures followed were compatible with the ethical standards of the responsible committee on human experimentation (institutional and national) and with the Helsinki Declaration of 1964 and later versions.

Conflicts of Interest

The authors declare no conflicts of interest.

References

  1. Okaniwa, S. Role of conventional ultrasonography in the diagnosis of gallbladder polypoid lesions. J. Med. Ultrason. 2021, 48, 149–157. [Google Scholar] [CrossRef] [PubMed]
  2. Hashimoto, S.; Ohno, E.; Yamamoto, S.; Nakaoka, K.; Hirooka, Y. The role of contrast-enhanced endoscopic ultrasound for biliary diseases. J. Med. Ultrason. 2023, in print. [Google Scholar] [CrossRef]
  3. Imazu, H.; Uchiyama, Y.; Matsunaga, K.; Ikeda, K.I.; Kakutani, H.; Sasaki, Y.; Sumiyama, K.; Ang, T.L.; Omar, S.; Tajiri, H. Contrast-enhanced harmonic EUS with novel ultrasonographic contrast (Sonazoid) in the preoperative T-staging for pancreaticobiliary malignancies. Scand. J. Gastroenterol. 2010, 45, 732–738. [Google Scholar] [CrossRef]
  4. Fujimoto, T. How Can We Identify T1 or Shallow T2 Gallbladder Carcinoma Using Ultrasound? Comment on Okaniwa, S. How Can We Manage Gallbladder Lesions by Transabdominal Ultrasound? Diagnostics 2021, 11, 784. Diagnostics 2024, 14, 164. [Google Scholar] [CrossRef]
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Okaniwa, S. Reply to Fujimoto, T. Comment on “Okaniwa, S. How Can We Manage Gallbladder Lesions by Transabdominal Ultrasound? Diagnostics 2021, 11, 784”. Diagnostics 2024, 14, 167. https://doi.org/10.3390/diagnostics14020167

AMA Style

Okaniwa S. Reply to Fujimoto, T. Comment on “Okaniwa, S. How Can We Manage Gallbladder Lesions by Transabdominal Ultrasound? Diagnostics 2021, 11, 784”. Diagnostics. 2024; 14(2):167. https://doi.org/10.3390/diagnostics14020167

Chicago/Turabian Style

Okaniwa, Shinji. 2024. "Reply to Fujimoto, T. Comment on “Okaniwa, S. How Can We Manage Gallbladder Lesions by Transabdominal Ultrasound? Diagnostics 2021, 11, 784”" Diagnostics 14, no. 2: 167. https://doi.org/10.3390/diagnostics14020167

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop